November 17, 2016 - By Pete Kolinski · 0 Comments
Kewaunee Scientific Corp (NASDAQ:KEQU) institutional sentiment decreased to 0.45 in Q2 2016. Its down -0.75, from 1.2 in 2016Q1. The ratio has dropped, as 5 funds opened new or increased stock positions, while 11 cut down and sold their stakes in Kewaunee Scientific Corp. The funds in our partner’s database now have: 798,690 shares, down from 852,161 shares in 2016Q1. Also, the number of funds holding Kewaunee Scientific Corp in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 9 Increased: 2 New Position: 3.
Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The company has a market cap of $61.68 million. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. It has a 14.75 P/E ratio. It operates through two divisions: Domestic and International.
About 397 shares traded hands. Kewaunee Scientific Corporation (NASDAQ:KEQU) has risen 34.08% since April 15, 2016 and is uptrending. It has outperformed by 29.46% the S&P500.
According to Zacks Investment Research, “Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company’s corporate headquarters and domestic manufacturing facilities are located in Statesville, North Carolina. The Company also has subsidiaries in Singapore and Bangalore, India that serve the Asian markets.”
Morgan Dempsey Capital Management Llc holds 0.25% of its portfolio in Kewaunee Scientific Corporation for 39,826 shares. North Star Investment Management Corp. owns 64,745 shares or 0.22% of their US portfolio. Moreover, Perritt Capital Management Inc has 0.13% invested in the company for 26,950 shares. The North Carolina-based Carroll Financial Associates Inc. has invested 0.02% in the stock. Bridgeway Capital Management Inc, a Texas-based fund reported 19,500 shares.#img1#
Kewaunee Scientific Corporation, incorporated on June 15, 1970, is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. The Firm operates through two divisions: Domestic and International. The Domestic business segment principally designs, makes, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, worksurfaces, workstations, workbenches and computer enclosures. The International business segment provides the Company’s services and products, including facility design, engineering, construction and project management from the planning stage through testing and commissioning of laboratories.
More notable recent Kewaunee Scientific Corporation (NASDAQ:KEQU) news were published by: Prnewswire.com which released: “Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2017 …” on November 15, 2016, also Prnewswire.com with their article: “Kewaunee Scientific Reports Results for First Quarter” published on August 30, 2016, Prnewswire.com published: “Kewaunee Scientific Awarded $18.5 Million Contract in Kuwait” on September 19, 2016. More interesting news about Kewaunee Scientific Corporation (NASDAQ:KEQU) were released by: Prnewswire.com and their article: “Kewaunee Scientific Reports Results for Fourth Quarter and Fiscal Year” published on June 21, 2016 as well as Prnewswire.com‘s news article titled: “Kewaunee Scientific Announces CFO Retirement” with publication date: July 16, 2015.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Pete Kolinski